Timothy Sullivan - 08 Jun 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: Chief Financial Officer
Signature: /s/ David Watson as attorney-in-fact for Timothy Sullivan
Issuer symbol: APLS
Transactions as of: 08 Jun 2021
Net transactions value: +$399,996
Form type: 4
Filing time: 09 Jun 2021, 16:06:00 UTC
Next filing: 25 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Options Exercise	$399,996	+39,880	+116%	$10.03	74,141	08 Jun 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APLS	Stock Option (Right to Buy)	Options Exercise	$0	-39,880	-10%	$0.000000	358,619	08 Jun 2021	Common Stock	39,880	$10.03	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on October 18, 2017 and will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.